Showing 2,201 - 2,220 results of 101,552 for search '(( 5 we decrease ) OR ( 5 ((((fold decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.84s Refine Results
  1. 2201
  2. 2202
  3. 2203
  4. 2204
  5. 2205

    Classification and regression tree: CYP3A5 phenotype discriminates between cases and tolerants (EM = normal metabolizers, IM and PM = decrease function, UM and UMH = increase function). by Luciana Kase Tanno (785410)

    Published 2015
    “…<p>Classification and regression tree: CYP3A5 phenotype discriminates between cases and tolerants (EM = normal metabolizers, IM and PM = decrease function, UM and UMH = increase function).…”
  6. 2206
  7. 2207
  8. 2208

    Visual stimuli. by Susana Martinez-Conde (389218)

    Published 2019
    “…These responses were measured along the fold and also at the 50% luminance (i.e. the midpoint on the fold) locations in the 0.5x0.5 DVA ROIs denoted by the small white square frames flanked by white arrows. …”
  9. 2209

    Image 1_A COP1-HY5-ABI5 module regulates ABA-mediated post-germination developmental arrest.pdf by Deeksha Singh (11009626)

    Published 2025
    “…Together, our results support a model in which a double-negative feedback loop between HY5 and ABI5 contributes to ABA-mediated post-germination growth arrest.…”
  10. 2210
  11. 2211
  12. 2212
  13. 2213
  14. 2214
  15. 2215
  16. 2216

    Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

    Published 2021
    “…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”
  17. 2217

    Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

    Published 2021
    “…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”
  18. 2218

    Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure by Wei Meng (505670)

    Published 2021
    “…Due to the increased polarity at C2, the permeability for these compounds decreased. Further adjustment of the polarity by replacing the N1 2,6-dimethoxyphenyl group with a 2,6-diethylphenyl group and reoptimization for the potency of the C5 pyrroloamides resulted in potent compounds with improved permeability. …”
  19. 2219
  20. 2220